![Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study - The Lancet ... Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study - The Lancet ...](https://www.thelancet.com/cms/asset/eff521c8-8eef-4742-84fa-adb3df91181b/gr1.jpg)
Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study - The Lancet ...
![Integrated host-microbe plasma metagenomics for sepsis diagnosis in a prospective cohort of critically ill adults | Nature Microbiology Integrated host-microbe plasma metagenomics for sepsis diagnosis in a prospective cohort of critically ill adults | Nature Microbiology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41564-022-01237-2/MediaObjects/41564_2022_1237_Fig1_HTML.png)
Integrated host-microbe plasma metagenomics for sepsis diagnosis in a prospective cohort of critically ill adults | Nature Microbiology
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis | PLOS Medicine
![The importance of blood pressure thresholds versus predicted cardiovascular risk on subsequent rates of cardiovascular disease: a cohort study in English primary care - The Lancet Healthy Longevity The importance of blood pressure thresholds versus predicted cardiovascular risk on subsequent rates of cardiovascular disease: a cohort study in English primary care - The Lancet Healthy Longevity](https://www.thelancet.com/cms/asset/6e8b92d4-8f0e-467e-9afd-83ac5b7d66b4/gr1.jpg)
The importance of blood pressure thresholds versus predicted cardiovascular risk on subsequent rates of cardiovascular disease: a cohort study in English primary care - The Lancet Healthy Longevity
Assessing biomass and primary production of microphytobenthos in depositional coastal systems using spectral information | PLOS ONE
![Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial - The Lancet Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial - The Lancet](https://www.thelancet.com/cms/asset/04f3d1bc-8493-4bfa-9572-fc2f5606352f/gr1.jpg)
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial - The Lancet
![Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21 - The Lancet Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21 - The Lancet](https://www.thelancet.com/cms/asset/33676324-183e-40d4-8810-e27d8df79b58/gr1.jpg)
Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21 - The Lancet
![Spatiotemporal proteomic profiling of the pro-inflammatory response to lipopolysaccharide in the THP-1 human leukaemia cell line | Nature Communications Spatiotemporal proteomic profiling of the pro-inflammatory response to lipopolysaccharide in the THP-1 human leukaemia cell line | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-26000-9/MediaObjects/41467_2021_26000_Fig1_HTML.png)
Spatiotemporal proteomic profiling of the pro-inflammatory response to lipopolysaccharide in the THP-1 human leukaemia cell line | Nature Communications
![Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses - The Lancet Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses - The Lancet](https://www.thelancet.com/cms/attachment/4e975ca1-4009-4d5c-b0cf-91de24db7b95/gr1.jpg)